Based on the Agios Pharm stock forecast from 4 analysts, the average analyst target price for Agios Pharm is USD 56.63 over the next 12 months. Agios Pharm’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Agios Pharm is Neutral, which is based on 3 positive signals and 3 negative signals. At the last closing, Agios Pharm’s stock price was USD 34.19. Agios Pharm’s stock price has changed by -12.38% over the past week, -40.55% over the past month and +42.82% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for AGIO !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
